Thus, our findings of significantly lower levels of miR-149-5p in stable CAD patients support its active role in the development of atherosclerosis through regulating genes involved in the lipid metabolism as well as suppressing STAT3- or ATF6-mediated inflammation31,34. Here, STAT3 is linked to atherosclerosis.